1. Beloglazov, D.V. Ocenka effektivnosti novogo preparata Ekspress Uspokoin® tabletki pri situacionnoy korrekcii povedencheskih problem u koshek / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2023. – № 2. – S. 14-22. – DOIhttps://doi.org/10.32416/2500-4379-2023-2-14-22.
2. Beloglazov, D.V. Ocenka effektivnosti novogo preparata «Ekspress Uspokoin® tabletki» pri situacionnoy korrekcii povedencheskih problem u sobak / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Sovremennaya veterinarnaya medicina. – 2023. ‒ № 1. ‒ C. 18-22.
3. Elizarova, E.A. Ocenka effektivnosti novogo lekarstvennogo preparata Kurs Uspokoin tabletki dlya korrekcii vozrastnyh kognitivnyh narusheniy u koshek / E.A. Elizarova, D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2024. – № 3. – S. 27-33. – DOIhttps://doi.org/10.32416/2500-4379-2024-3-27-33.
4. Beloglazov, D.V. Trazodona sukcinat ‒ novye vozmozhnosti farmakologicheskoy korrekcii situacionnyh povedencheskih otkloneniy u sobak i koshek / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2021. – № 4. – S. 5-13. – DOIhttps://doi.org/10.32416/2500-4379-2021-4-5-13.
5. Kurs Uspokoin tabletki. Instrukciya po veterinarnomu primeneniyu lekarstvennogo preparata [Elektronnyy resurs]. https://galen.vetrf.ru/files/5c1ac33d-9461-4add-bd1c-e04b2d82f1fb (data obrascheniya 21.01.25).
6. Prikaz Ministerstva sel'skogo hozyaystva RF №101 ot 06.03.2018 g. «Ob utverzhdenii Pravil provedeniya doklinicheskogo issledovaniya lekarstvennogo sredstva dlya veterinarnogo primeneniya, klinicheskogo issledovaniya lekarstvennogo preparata dlya veterinarnogo primeneniya, issledovaniya bioekvivalentnosti lekarstvennogo preparata dlya veterinarnogo primeneniya». Zaregistrirovan v Minyuste Rossii 05.06.2018 № 51296.
7. Rukovodstvo po provedeniyu doklinicheskih issledovaniy lekarstvennyh sredstv. Chast' pervaya / A.N. Mironov, N.D. Bunatyan i dr. – M.: Grif i K, 2012. – 944 s.
8. Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novyh farmakologicheskih veschestv / Pod red. R. U. Habrieva. – M.: Medicina, 2005. – 832s.
9. Smirnov, A.V. Yantarnaya kislota i ee primenenie v medicine. Chast' I. Yantarnaya kislota: metabolit i regulyator metabolizma organizma cheloveka / A.V. Smirnov, O.B. Nesterova, R.V. Golubev // Nefrologiya. – 2014. – T. 18. – № 2. – S. 33-41.
10. Ekspress Uspokoin® tabletki. Instrukciya po veterinarnomu primeneniyu lekarstvennogo preparata [Elektronnyy resurs]. https://galen.vetrf.ru/files/41fc97ef-69b3-4502-bded-57bb87220cd6 (data obrascheniya 21.01.25).
11. Adrian, D.E. Prescribing practices of veterinarians in the treatment of chronic musculoskeletal pain in cats / D.E. Adrian, M. Rishniw, M. Scherk, et al. // J Feline Med Surg. ‒ 2019 Jun. ‒ No. 21 (6). ‒ hh. 495-506. doi:https://doi.org/10.1177/1098612X18787910.
12. Boyle, Y. The effect of a combination of gabapentin and donepezil in an experimental pain model in healthy volunteers: Results of a randomized controlled trial / Y. Boyle, D. Fernando, H. Kurz, S.R. Miller, M. Zucchetto, J. Storey // Pain. ‒ 2014. ‒ No. 155(12). ‒ pp. 2510-2516. doihttps://doi.org/10.1016/j.pain.2014.09.003.
13. Cheng, H.F. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors / H.F. Cheng, R.C. Harris // Curr Pharm Des. ‒ 2005. ‒ No. 11(14). ‒ pp. 1795-1804. doihttps://doi.org/10.2174/1381612053764922.
14. Chincholkar, M. Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review / M. Chincholkar // Br J Anaesth. ‒ 2018. ‒ No. 120(6). ‒ pp. 1315-1334. doihttps://doi.org/10.1016/j.bja.2018.02.066.
15. Edwards, R.R. Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis / R.R. Edwards, A.J. Dolman, M.O. Martel, et al. // BMC Musculoskelet Disord. ‒ 2016. ‒ No. 17. ‒ pp. 284. Published 2016 Jul 13. doihttps://doi.org/10.1186/s12891-016-1124-6.
16. Enomoto M., Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats / M. Enomoto, P.W. Mantyh, J. Murrell, J.F. Innes, B.D.X. Lascelles // Vet Rec. ‒ 2019. ‒ No. 184(1). ‒ pp. 23. doihttps://doi.org/10.1136/vr.104590.
17. Garrone, B. Synergistic interaction between trazodone and gabapentin in rodent models of neuropathic pain / B. Garrone // PLoS One. ‒ 2021. ‒ No. 16(1). ‒ e0244649.
18. Garry, E.M. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs / E.M. Garry, A. Delaney, H.A. Anderson, et al. // Pain. ‒ 2005. ‒ No. 118 (1-2). ‒ pp. 97-111. doihttps://doi.org/10.1016/j.pain.2005.08.003.
19. Gilron, I. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial / J.M. Bailey, D. Tu, R.R. Holden, A.C. Jackson, R.L. Houlden // Lancet. ‒ 2009. ‒ No. 374(9697). ‒ pp. 1252-1261. doihttps://doi.org/10.1016/S0140-6736(09)61081-3.
20. Godfrey, D.R. Osteoarthritis in cats: a retrospective radiological study / D.R. Godfrey // J Small Anim Pract. ‒ 2005. ‒ No. 46(9). ‒ pp. 425-429. doihttps://doi.org/10.1111/j.1748-5827.2005.tb00340.x
21. Gruen, M.E. Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain / M.E. Gruen, E. Griffith, A. Thomson, et al. // J Vet Intern Med. ‒ 2014. ‒No. 28(2). ‒ pp. 346-350.
22. Gruen, M.E. AAHA Pain Management Guidelines for Dogs and Cats. / M.E. Gruen, B.D.X. Lascelles, E. Colleran, et al. // J Am Anim Hosp Assoc. ‒ 2022. ‒ No. 58(2). ‒ pp. 55-76. doihttps://doi.org/10.5326/JAAHA-MS-7292.
23. Gruen, M.E. A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study. / M.E. Gruen, A.E. Thomson, E.H. Griffith, H. Paradise, D.P. Gearing, // J Vet Intern Med. ‒ 2016. ‒ No. 30(4). ‒ pp. 1138-1148. doihttps://doi.org/10.1111/jvim.13972.
24. Guedes, A.G.P. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impirment and quality of life in osteoarthritic geriatric cats / A.G.P. Guedes, J.M. Meadows, B.H. Pypendop, et al. // J Am Vet Med Assoc. ‒ 2018. ‒ No. 253(5). ‒ pp. 579-85.
25. Hardie, E.M. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994-1997) / E.M. Hardie, S.C. Roe, F.R. Martin // J Am Vet Med Assoc. ‒ 2002. ‒ No. 220(5). ‒ pp. 628-632. doihttps://doi.org/10.2460/javma.2002.220.628
26. Heughan, C.E. The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration / C.E. Heughan, J. Sawynok // Anesth Analg. ‒ 2002. ‒ No. 94(4). ‒ pp. 975-980. doihttps://doi.org/10.1097/00000539-200204000-00037.
27. Liu, V.W.C. Antidepressants for the Treatment of Neuropathic Pain / V.W.C. Liu, L.W. Lam, H.F.K. Chiu // Hong Kong J Psychiatry. ‒ 2002. ‒ No. 12(4). ‒ pp. 23-27.
28. Lascelles B.D.X. Management of chronic cancer pain / B.D.X. Lascelles. In: Withrow S, Vail D, Page R. (eds). Small animal clinical oncology. St Louis, MO: Elsevier, 2013, pp 245-259.
29. Martell-Moran, N.K. Pain and adverse behavior in declawed cats / N.K. Martell-Moran, M. Solano, H.G. Townsend // J Feline Med Surg. ‒ 2018. ‒ No. 20(4). ‒ pp. 280-288. doihttps://doi.org/10.1177/1098612X1770504.
30. Mizisin, A.P. Neurological complications associated with spontaneously occurring feline diabetes mellitus / A.P. Mizisin, G.D. Shelton, M.L. Burgers, H.C. Powell, P.A. Cuddon // J Neuropathol Exp Neurol. ‒ 2002. ‒ No. 61(10). ‒ pp. 872-884. doihttps://doi.org/10.1093/jnen/61.10.872.
31. Monteiro, B.P. Chronic pain in cats: Recent advances in clinical assessment / B.P. Monteiro, P.V. Steagall // J Feline Med Surg. ‒ 2019. ‒ No. 21(7). ‒ pp. 601-614. doihttps://doi.org/10.1177/1098612X19856179
32. Muthuraman, A. Drug therapy of neuropathic pain: current developments and future perspectives / A. Muthuraman, N. Singh, A.S. Jaggi, M. Ramesh // Curr Drug Targets. ‒ 2014. ‒ No. 15(2). ‒ pp. 210-253.
33. Oggianu, L. PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK-PD modeling from nonclinical to clinical development / L. Oggianu, B. Garrone, F. Fiorentini, et al. // Clin Transl Sci. ‒ 2023. ‒ No. 16(4). ‒ pp. 606-617. doihttps://doi.org/10.1111/cts.13472.
34. Okuda, K. Trazodone hydrochloride attenuates thermal hyperalgesia in a chronic constriction injury rat model / K. Okuda, T. Takanishi, K. Yoshimoto, S. Ueda // Eur J Anaesthesiol. ‒ 2003. ‒ No. 20(5). ‒ pp. 409-415. doihttps://doi.org/10.1017/s0265021503000632.
35. Patel, R. Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain / R. Patel, A.H. Dickenson // Pharmacol Res Perspect. ‒ 2016. ‒ No. 4(2). ‒ e00205. Published 2016 Feb 27. doihttps://doi.org/10.1002/prp2.205.
36. Petrere, J.A. Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin / J.A. Petrere, J.A. Anderson // Fundam Appl Toxicol. ‒ 1994. ‒ No. 23(4). ‒ pp. 585-589. doihttps://doi.org/10.1006/faat.1994.1144.
37. Slingerland, L.I. Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats / L.I. Slingerland, H.A. Hazewinkel, B.P. Meij, P. Picavet, G. Voorhout // Vet J. ‒ 2011. ‒ No. 187(3). ‒ pp. 304-309. doihttps://doi.org/10.1016/j.tvjl.2009.12.014.
38. Sparkes, A.H. ISFM consensus guidelines on the practical management of diabetes mellitus in cats / A.H. Sparkes, M. Cannon, D. Church, et al. // J Feline Med Surg. ‒ 2015. ‒ No. 17(3). ‒ pp. 235-250. doihttps://doi.org/10.1177/1098612X15571880.
39. Stahl, S.M. Mechanism of action of trazodone: a multifunctional drug / S.M. Stahl // CNS Spectr. ‒ 2009. ‒ No. 14(10). ‒ pp. 536-546. doihttps://doi.org/10.1017/s1092852900024020.
40. Steagall, P.V. Multimodal analgesia for perioperative pain in three cats / P.V. Steagall, B.P. Monteiro-Steagall // J Feline Med Surg. ‒ 2013. ‒ No. 15(8). ‒ pp. 737-743. doihttps://doi.org/10.1177/1098612X13476033.
41. Taylor, C.P. Mechanisms of action of gabapentin / C.P. Taylor // Rev Neurol (Paris). ‒ 1997. ‒ No. 153 Suppl 1. ‒ S39-S45.
42. Vasudevan, R. Alleviation of neuropathic pain by trazodone in rats / R. Vasudevan // Brazilian Journal of Pharmaceutical Sciences. ‒ 2022. ‒ No. 58. ‒ e19256.
43. Walsh, K. Chronic pain management in dogs and cats / K. Walsh // In Pract. ‒ 2016. ‒ No. 38. ‒ pp. 155-65. doi:https://doi.org/10.1136/inp.i1489
44. Watanabe, R. A multidisciplinary study of pain in cats undergoing dental extractions: A prospective, blinded, clinical trial / R. Watanabe, G. Doodnaught, C. Proulx, et al. // PLoS One. ‒ 2019. ‒ No. 14(3). ‒ e0213195. Published 2019 Mar 1. doihttps://doi.org/10.1371/journal.pone.0213195.
45. Watanabe, R. Pain behaviors before and after treatment of oral disease: preliminary results / R. Watanabe, D. Frank, P. Steagall. In: Proceeding of 8th Annual Congress of Asian Society of Veterinary Surgery. Taichung, Taiwan, 2018. pp.1-11.
